Celgene celgene.com

Celgene is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. On November 21, 2019, Celgene was acquired by Bristol-Myers Squibb at a valuation of $74B.

Celgene is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasi...Show all

See All Exits Recent Exits

Phone: 908-673-9000

Fax:

86 Morris Avenue

 Summit, 07901
 New Jersey, United States

Celgene - Investments & Acquisitions

Show Real Data Celgene Investments
See all Recent Investments
Date Company Round Amount Co-investors
2019-10-15Cyteir TherapeuticsSeries B - II$40.2MDROIA Oncology Ventures, Lightstone Ventures, Novo Ventures, Osage University Partners, and Venrock
2019-09-11AnokionSeries B$40MNovartis Venture Funds, Novo Ventures, and Versant Ventures
2019-08-28Immatics BiotechnologiesPartnership - II$75M
2019-08-20OncorusSeries B$79.5MArkin Holdings, Astellas Venture Management, Cowen, Deerfield Management, IMM Investment, MPM Capital, Perceptive Advisors, QUAD Investment Management, Shinhan Capital, Sphera Funds, Surveyor Capital, SV Investment, UBS, and UTC Investment
2019-06-24OtezlaSpinoff / Spinout
See all 5 investments